The utility of serum tryptase as a marker in chronic spontaneous urticaria

Acta Dermato-Venereologica

Volumn 93, Issue 3, 2013, Pages 354-355

  Siles, Roxana ^a   Xu, Meng ^b   Hsieh, Fred H ^c  

^a Respiratory Institute   (United States)

^b Department of Quantitative Health Sciences ^*  (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPTASE;

ADULT; CHRONIC SPONTANEOUS URTICARIA; CLINICAL FEATURE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URTICARIA;

ADULT; AGED; BIOLOGICAL MARKERS; CHRONIC DISEASE; CLINICAL ENZYME TESTS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; STEROIDS; TRYPTASES; UP-REGULATION; URTICARIA;

EID: 84876992271     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1486     Document Type: Letter

References (10)

1. The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema part II: chronic urticaria/angioedema. Joint Task Force on Practice Parameters. Ann Allergy Asthma Immunol 2000; 85: 521-544.
2. Kaplan AP, Greaves M. Pathogenesis of chronic urticaria. Clin Exp Allergy 2009; 39: 777-787.
3. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 2006; 26: 451-463.
4. Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K, et al. Standards and standardization in mas-tocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37: 435-453.
5. Bruno G, Andreozzi P, Magrini L, Graf U, Santangelo G, Zaino S. Mast cell activation in acquired chronic urticaria-angioedema. Sci Total Environ 2001; 270: 77-81.
6. Hidvegi B, Nagy E, Szabo T, Temesvari E, Marschalko M, Karpati S, et al. Correlation between T-cell and mast cell activity in patients with chronic urticaria. Int Arch Allergy Immunol 2003; 132: 177-182.
7. Ferrer M, Nunez-Cordoba JM, Luquin E, Grattan CE, De la Borbolla JM, Sanz ML, et al. Serum total tryptase levels are increased in patients with active chronic urticaria. Clin Exp Allergy 2010; 40: 1760-1766.
8. Alyasin S, Hamidi M, Karimi AA, Amiri A, Ghaffarpasand F, Ehsaei MJ. Correlation between clinical fndings and results of autologous serum skin test in patients with chronic idiopathic urticaria. South Med J 2011; 104: 111-115.
9. Schliemann S, Seyfarth F, Hipler UC, Elsner P. Impact of age and heterophilic interference on the basal serum tryp-tase, a risk indication for anaphylaxis, in 1,092 dermatology patients. Acta Derm Venereol 2011; 91: 484-489.
10. Cohan VL, Undem BJ, Fox CC, Adkinson NF, Lichten-stein LM, Schleimer RP. Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin. Am Rev Respir Dis 1989; 140: 951-954.